The role of E3 ubiquitin ligases in bone homeostasis and related diseases

被引:14
作者
Dong, Yuechao [1 ]
Chen, Yangshan [1 ]
Ma, Guixing [1 ]
Cao, Huiling [1 ]
机构
[1] Southern Univ Sci & Technol, Key Univ Lab Metab & Hlth Guangdong, Guangdong Prov Key Lab Cell Microenvironm & Dis Re, Dept Biochem,Sch Med, Shenzhen 518055, Peoples R China
基金
中国国家自然科学基金;
关键词
E3 ubiquitin ligase; UPS; Osteogenesis; Bone resorption; Osteoblast; Osteoclast; Chondrocyte; PROTAC; REGULATES OSTEOBLAST DIFFERENTIATION; B-ALPHA UBIQUITINATION; PROTEIN-KINASE-D; NF-KAPPA-B; PROSTATE-CANCER; BETA-TRCP; TGF-BETA; BREAST-CANCER; CBL-B; OSTEOGENIC DIFFERENTIATION;
D O I
10.1016/j.apsb.2023.06.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ubiquitin-proteasome system (UPS) dedicates to degrade intracellular proteins to modu-late demic homeostasis and functions of organisms. These enzymatic cascades mark and modifies target proteins diversly through covalently binding ubiquitin molecules. In the UPS, E3 ubiquitin ligases are the crucial constituents by the advantage of recognizing and presenting proteins to proteasomes for proteol-ysis. As the major regulators of protein homeostasis, E3 ligases are indispensable to proper cell manners in diverse systems, and they are well described in physiological bone growth and bone metabolism. Path-ologically, classic bone-related diseases such as metabolic bone diseases, arthritis, bone neoplasms and bone metastasis of the tumor, etc., were also depicted in a UPS-dependent manner. Therefore, skeletal system is versatilely regulated by UPS and it is worthy to summarize the underlying mechanism. Further-more, based on the current status of treatment, normal or pathological osteogenesis and tumorigenesis elaborated in this review highlight the clinical significance of UPS research. As a strategy possibly rem-edies the limitations of UPS treatment, emerging PROTAC was described comprehensively to illustrate its potential in clinical application. Altogether, the purpose of this review aims to provide more evidence for exploiting novel therapeutic strategies based on UPS for bone associated diseases.(c) 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:3963 / 3987
页数:25
相关论文
共 248 条
[1]  
Adam Zdenek, 2016, Vnitr Lek, V62, P114
[2]   Dynamics of protein synthesis and degradation through the cell cycle [J].
Alber, Andrea Brigitta ;
Suter, David Michael .
CELL CYCLE, 2019, 18 (08) :784-794
[3]   Diagnosis and Management of Rheumatoid Arthritis A Review [J].
Aletaha, Daniel ;
Smolen, Josef S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (13) :1360-1372
[4]  
Allgrove J, 2015, ENDOCR DEV, V28, P119, DOI 10.1159/000381000
[5]   Genetic diseases of acid-base transporters [J].
Alper, SL .
ANNUAL REVIEW OF PHYSIOLOGY, 2002, 64 :899-923
[6]   Modern radiotherapy for head and neck cancer [J].
Alterio, Daniela ;
Marvaso, Giulia ;
Ferrari, Annamaria ;
Volpe, Stefania ;
Orecchia, Roberto ;
Jereczek-Fossaa, Barbara Alicja .
SEMINARS IN ONCOLOGY, 2019, 46 (03) :233-245
[7]   Paget's disease of bone [J].
Appelman-Dijkstra, Natasha M. ;
Papapoulos, Socrates E. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 32 (05) :657-668
[8]   Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis [J].
Appelman-Dijkstra, Natasha M. ;
Papapoulos, Socrates E. .
DRUGS, 2015, 75 (10) :1049-1058
[9]   Selective Wee1 degradation by PROTAC degraders recruiting VHL and CRBN E3 ubiquitin ligases [J].
Aublette, Marine C. ;
Harrison, Tom A. ;
Thorpe, Elizabeth J. ;
Gadd, Morgan S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 64
[10]   Modeling the Skeleton Weight of an Adult Caucasian Man [J].
Avtandilashvili, Maia ;
Tolmachev, Sergei Y. .
HEALTH PHYSICS, 2019, 117 (02) :149-155